207 related articles for article (PubMed ID: 30498046)
1. Residual pulmonary vascular obstruction and recurrence after acute pulmonary embolism: protocol for a systematic review and meta-analysis of individual participant data.
Robin P; Eddy M; Sikora L; Le Roux PY; Carrier M; Couturaud F; Planquette B; Pesavento R; Rodger M; Salaun PY; Le Gal G
BMJ Open; 2018 Nov; 8(11):e023939. PubMed ID: 30498046
[TBL] [Abstract][Full Text] [Related]
2. Residual pulmonary vascular obstruction and recurrence after acute pulmonary embolism: a systematic review and meta-analysis of individual participant data.
Robin P; Le Pennec R; Eddy M; Sikora L; Le Roux PY; Carrier M; Couturaud F; Tromeur C; Planquette B; Sanchez O; Pesavento R; Filippi L; Rodger MA; Kovacs MJ; Mallick R; Salaun PY; Le Gal G
J Thromb Haemost; 2023 Jun; 21(6):1519-1528.e2. PubMed ID: 36740040
[TBL] [Abstract][Full Text] [Related]
3. Residual pulmonary vascular obstruction and recurrence after acute pulmonary embolism. A single center cohort study.
Planquette B; Ferré A; Peron J; Vial-Dupuy A; Pastre J; Mourin G; Emmerich J; Collignon MA; Meyer G; Sanchez O
Thromb Res; 2016 Dec; 148():70-75. PubMed ID: 27815969
[TBL] [Abstract][Full Text] [Related]
4. Residual pulmonary embolism as a predictor for recurrence after a first unprovoked episode: Results from the REVERSE cohort study.
Wan T; Rodger M; Zeng W; Robin P; Righini M; Kovacs MJ; Tan M; Carrier M; Kahn SR; Wells PS; Anderson DR; Chagnon I; Solymoss S; Crowther M; White RH; Vickars L; Bazarjani S; Le Gal G
Thromb Res; 2018 Feb; 162():104-109. PubMed ID: 29224973
[TBL] [Abstract][Full Text] [Related]
5. Risk of recurrent venous thromboembolism after acute pulmonary embolism: Role of residual pulmonary obstruction and persistent right ventricular dysfunction. A meta-analysis.
Becattini C; Giustozzi M; Cerdà P; Cimini LA; Riera-Mestre A; Agnelli G
J Thromb Haemost; 2019 Aug; 17(8):1217-1228. PubMed ID: 31063646
[TBL] [Abstract][Full Text] [Related]
6. Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis.
Khan F; Rahman A; Carrier M; Kearon C; Weitz JI; Schulman S; Couturaud F; Eichinger S; Kyrle PA; Becattini C; Agnelli G; Brighton TA; Lensing AWA; Prins MH; Sabri E; Hutton B; Pinede L; Cushman M; Palareti G; Wells GA; Prandoni P; Büller HR; Rodger MA;
BMJ; 2019 Jul; 366():l4363. PubMed ID: 31340984
[TBL] [Abstract][Full Text] [Related]
7. Antiplatelet agents for the treatment of deep venous thrombosis.
Flumignan CD; Nakano LC; Baptista-Silva JC; Flumignan RL
Cochrane Database Syst Rev; 2022 Jul; 7(7):CD012369. PubMed ID: 35876829
[TBL] [Abstract][Full Text] [Related]
8. Long-term prognostic value of residual pulmonary vascular obstruction at discharge in patients with intermediate- to high-risk pulmonary embolism.
Meneveau N; Ider O; Seronde MF; Chopard R; Davani S; Bernard Y; Schiele F
Eur Heart J; 2013 Mar; 34(9):693-701. PubMed ID: 23103660
[TBL] [Abstract][Full Text] [Related]
9. Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism.
Robertson L; Strachan J
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD006771. PubMed ID: 28195640
[TBL] [Abstract][Full Text] [Related]
10. Detection of Residual Pulmonary Vascular Obstruction by Ventilation-Perfusion Lung Scan Late After a First Pulmonary Embolism.
Chopard R; Genet B; Ecarnot F; Chatot M; Napporn G; Hyvert A; Didier-Petit K; Schiele F; Meneveau N
Am J Cardiol; 2017 Jun; 119(11):1883-1889. PubMed ID: 28400030
[TBL] [Abstract][Full Text] [Related]
11. Long-term risk of recurrence after discontinuing anticoagulants for a first unprovoked venous thromboembolism: protocol for a systematic review and meta-analysis.
Khan F; Rahman A; Carrier M; Kearon C; Schulman S; Couturaud F; Prandoni P; Eichinger S; Becattini C; Agnelli G; Büller HR; Brighton TA; Palareti G; Pinede L; Sabri E; Hutton B; Wells GA; Rodger MA;
BMJ Open; 2017 Sep; 7(9):16950. PubMed ID: 28939565
[TBL] [Abstract][Full Text] [Related]
12. Extended Anticoagulant and Aspirin Treatment for the Secondary Prevention of Thromboembolic Disease: A Systematic Review and Meta-Analysis.
Marik PE; Cavallazzi R
PLoS One; 2015; 10(11):e0143252. PubMed ID: 26587983
[TBL] [Abstract][Full Text] [Related]
13. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients.
Prandoni P; Noventa F; Ghirarduzzi A; Pengo V; Bernardi E; Pesavento R; Iotti M; Tormene D; Simioni P; Pagnan A
Haematologica; 2007 Feb; 92(2):199-205. PubMed ID: 17296569
[TBL] [Abstract][Full Text] [Related]
14. SPECT V/Q for the diagnosis of pulmonary embolism: protocol for a systematic review and meta-analysis of diagnostic accuracy and clinical outcome.
Le Roux PY; Robin P; Tromeur C; Davis A; Robert-Ebadi H; Carrier M; Couturaud F; Le Gal G; Salaun PY
BMJ Open; 2018 Apr; 8(4):e022024. PubMed ID: 29680814
[TBL] [Abstract][Full Text] [Related]
15. Shorter or longer anticoagulation to prevent recurrent venous thromboembolism: systematic review and meta-analysis.
Lopes LC; Eikelboom J; Spencer FA; Akl EA; Kearon C; Neumann I; Schulman S; Bhatnagar N; Guyatt G
BMJ Open; 2014 Jul; 4(7):e005674. PubMed ID: 24996916
[TBL] [Abstract][Full Text] [Related]
16. Risk of major bleeding during extended oral anticoagulation in patients with first unprovoked venous thromboembolism: a systematic review and meta-analysis protocol.
Khan F; Kimpton M; Tritschler T; Le Gal G; Hutton B; Fergusson DA; Rodger MA
Syst Rev; 2019 Oct; 8(1):245. PubMed ID: 31661033
[TBL] [Abstract][Full Text] [Related]
17. Predictors of residual pulmonary vascular obstruction after pulmonary embolism: Results from a prospective cohort study.
Picart G; Robin P; Tromeur C; Orione C; Raj L; Ferrière N; Le Mao R; Le Roux PY; Le Floch PY; Lemarié CA; Nonent M; Leroyer C; Guegan M; Lacut K; Salaün PY; Couturaud F
Thromb Res; 2020 Oct; 194():1-7. PubMed ID: 32554255
[TBL] [Abstract][Full Text] [Related]
18. Risk of recurrence in patients with pulmonary embolism: predictive role of D-dimer and of residual perfusion defects on lung scintigraphy.
Poli D; Cenci C; Antonucci E; Grifoni E; Arcangeli C; Prisco D; Abbate R; Miniati M
Thromb Haemost; 2013 Feb; 109(2):181-6. PubMed ID: 23196319
[TBL] [Abstract][Full Text] [Related]
19. Effect of testing for cancer on cancer- or venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.
Robertson L; Yeoh SE; Broderick C; Stansby G; Agarwal R
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD010837. PubMed ID: 30407621
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Venous Thromboembolism Recurrence Scores in an Unprovoked Pulmonary Embolism Population: A Post-hoc Analysis of the PADIS-PE trial.
Raj L; Presles E; Le Mao R; Robin P; Sanchez O; Pernod G; Bertoletti L; Jego P; Lemarié CA; Leven F; Hoffmann C; Planquette B; Le Roux PY; Slaun PY; Nonent M; Girard P; Lacut K; Mélac S; Guégan M; Mismetti P; Laporte S; Meyer G; Leroyer C; Tromeur C; Couturaud F;
Am J Med; 2020 Aug; 133(8):e406-e421. PubMed ID: 32333853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
